Search research articles
Contact Us
Filters
Showing results (41-50 of 569) with videos related to
Page
of 57
Sort By:
Biochemical and Biophysical Research Communications
|
June 8, 2006
Serum- and glucocorticoid-regulated kinase 1 (SGK1) induction by the EWS/NOR1(NR4A3) fusion protein
Hugo Poulin, Christine Filion, Marc Ladanyi, et al.
The Lancet. Oncology
|
October 3, 2012
Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy
Alexander Drilon, Natasha Rekhtman, Marc Ladanyi, et al.
Seminars in Diagnostic Pathology
|
November 19, 2008
KRAS mutational testing in the selection of patients for EGFR-targeted therapies
Joaquin Garcia, Gregory J Riely, Khedoudja Nafa, et al.
The Journal of Molecular Diagnostics : JMD
|
July 24, 2003
Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification
Priti Lal, Paulo A Salazar, Marc Ladanyi, et al.
Archives of Pathology & Laboratory Medicine
|
December 29, 2020
Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing
Jinjuan Yao, Maria E Arcila, Marc Ladanyi, et al.
Plos One
|
April 2, 2015
BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line
Arianne Morrison, Yvonne Chekaluk, Ruben Bacares, et al.
Cancer
|
December 12, 2003
Imatinib mesylate in Philadelphia chromosome-positive leukemia of childhood
E Anders Kolb, Qiulu Pan, Marc Ladanyi, et al.
Lancet (London, England)
|
September 29, 2004
Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids
Fernando López-Ríos, Peter B Illei, Valerie Rusch, et al.
Oncology Reports
|
June 5, 2013
Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma
Eun Hyun Ahn, Gabriela E Mercado, Marick Laé, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 9, 2020
[Ⅱ.MSK-IMPACT of Bone and Soft Tissue Sarcomas in Japan]
Yoshiyuki Suehara, Takuo Hayashi, Tsuyoshi Saito, et al.
Page
of 57
Search research articles
Search
Showing results (41-50 of 569) with videos related to
Sort By:
Page
of 57
Biochemical and Biophysical Research Communications
|
June 8, 2006
Serum- and glucocorticoid-regulated kinase 1 (SGK1) induction by the EWS/NOR1(NR4A3) fusion protein
Hugo Poulin, Christine Filion, Marc Ladanyi, et al.
The Lancet. Oncology
|
October 3, 2012
Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy
Alexander Drilon, Natasha Rekhtman, Marc Ladanyi, et al.
Seminars in Diagnostic Pathology
|
November 19, 2008
KRAS mutational testing in the selection of patients for EGFR-targeted therapies
Joaquin Garcia, Gregory J Riely, Khedoudja Nafa, et al.
The Journal of Molecular Diagnostics : JMD
|
July 24, 2003
Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification
Priti Lal, Paulo A Salazar, Marc Ladanyi, et al.
Archives of Pathology & Laboratory Medicine
|
December 29, 2020
Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing
Jinjuan Yao, Maria E Arcila, Marc Ladanyi, et al.
Plos One
|
April 2, 2015
BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line
Arianne Morrison, Yvonne Chekaluk, Ruben Bacares, et al.
Cancer
|
December 12, 2003
Imatinib mesylate in Philadelphia chromosome-positive leukemia of childhood
E Anders Kolb, Qiulu Pan, Marc Ladanyi, et al.
Lancet (London, England)
|
September 29, 2004
Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids
Fernando López-Ríos, Peter B Illei, Valerie Rusch, et al.
Oncology Reports
|
June 5, 2013
Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma
Eun Hyun Ahn, Gabriela E Mercado, Marick Laé, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 9, 2020
[Ⅱ.MSK-IMPACT of Bone and Soft Tissue Sarcomas in Japan]
Yoshiyuki Suehara, Takuo Hayashi, Tsuyoshi Saito, et al.
Page
of 57